NMR-Based Metabolomics in Investigation of the Radiation Induced Changes in Blood Serum of Head and Neck Cancer Patients and Its Correlation with the Tissue Volumes Exposed to the Particulate Doses.
NMR
cancer
metabolomics
radiotherapy
toxicity
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
11 Jun 2021
11 Jun 2021
Historique:
received:
05
05
2021
revised:
08
06
2021
accepted:
08
06
2021
entrez:
2
7
2021
pubmed:
3
7
2021
medline:
15
7
2021
Statut:
epublish
Résumé
In the present study, we analyze the nuclear magnetic resonance (NMR) blood serum metabolic profiles of 106 head and neck squamous cell carcinoma (HNSCC) patients during radio (RT) and concurrent radio-chemotherapy (CHRT). Four different fractionation schemes were compared. The blood samples were collected weekly, from the day before the treatment until the last week of CHRT/RT. The NMR spectra were acquired on A Bruker 400 MHz spectrometer at 310 K and analyzed using multivariate methods. Seven metabolites were found significantly to be altered solely by radiotherapy: N-acetyl-glycoprotein (NAG), N-acetylcysteine, glycerol, glycolate and the lipids at 0.9, 1.3 and 3.2 ppm. The NMR results were correlated with the tissue volumes receiving a particular dose of radiation. The influence of the irradiated volume on the metabolic profile is weak and mainly limited to sparse correlations with the inflammatory markers, creatinine and the lymphocyte count in RT and the branched-chain amino-acids in CHRT. This is probably due to the optimal planning and delivery of radiotherapy improving sparing of the surrounding normal tissues and minimizing the differences between the patients (caused by the tumor location and size).
Identifiants
pubmed: 34208417
pii: ijms22126310
doi: 10.3390/ijms22126310
pmc: PMC8231285
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Références
Am J Physiol Endocrinol Metab. 2001 Nov;281(5):E998-1004
pubmed: 11595656
Clin Chem. 2015 May;61(5):714-23
pubmed: 25779987
Drug Des Devel Ther. 2018 Jul 16;12:2223-2231
pubmed: 30038488
Oncology. 2018;95(2):61-68
pubmed: 29895020
Molecules. 2018 Dec 13;23(12):
pubmed: 30551603
FEBS Lett. 1987 May 11;215(2):311-5
pubmed: 2438159
Radiat Res. 2011 Apr;175(4):473-84
pubmed: 21309707
Am J Mens Health. 2019 Mar-Apr;13(2):1557988319846328
pubmed: 31023130
Lancet. 2006 Sep 2;368(9538):843-54
pubmed: 16950362
Biomol Concepts. 2017 May 24;8(2):83-92
pubmed: 28574375
Inflamm Res. 2011 Jul;60(7):695-704
pubmed: 21424515
J Transl Med. 2017 Oct 27;15(1):219
pubmed: 29078787
Nat Med. 2014 Oct;20(10):1193-1198
pubmed: 25261994
PLoS One. 2015 Jul 06;10(7):e0129679
pubmed: 26146828
Cell Death Dis. 2019 Jul 15;10(8):540
pubmed: 31308358
Diabetes Obes Metab. 2019 Jan;21(1):178-182
pubmed: 30047224
Biopharm Drug Dispos. 1991 Jul;12(5):343-53
pubmed: 1878531
Mamm Genome. 2018 Dec;29(11-12):843-865
pubmed: 30178305
J Inherit Metab Dis. 2011 Feb;34(1):3-15
pubmed: 20446114
Curr Opin Struct Biol. 2021 Jun;68:9-17
pubmed: 33129067
Am J Clin Nutr. 2005 Jun;81(6):1378-82
pubmed: 15941890
Clin Oncol (R Coll Radiol). 2017 Apr;29(4):263-273
pubmed: 28057404
Metabolites. 2020 Aug 11;10(8):
pubmed: 32796693
J Proteome Res. 2018 Nov 2;17(11):3730-3739
pubmed: 30353728
Scand J Clin Lab Invest. 2013 Feb;73(1):61-6
pubmed: 23110331
J Cachexia Sarcopenia Muscle. 2019 Feb;10(1):140-154
pubmed: 30680954
Front Oncol. 2019 Oct 01;9:987
pubmed: 31632918
J Anim Sci. 1981 Jan;52(1):75-82
pubmed: 7240041
Radiat Oncol. 2019 Mar 18;14(1):49
pubmed: 30885235
Anal Biochem. 2012 Feb 1;421(1):121-4
pubmed: 22093610
Metabolomics. 2020 Nov 27;16(12):124
pubmed: 33245511
J Lipid Res. 2019 Sep;60(9):1516-1534
pubmed: 31239285
Int J Mol Sci. 2014 Apr 17;15(4):6609-24
pubmed: 24747595
J Proteome Res. 2011 Nov 4;10(11):5232-41
pubmed: 21961579
Lipids Health Dis. 2017 May 18;16(1):92
pubmed: 28521812
Semin Cancer Biol. 2018 Apr;49:83-93
pubmed: 28506645
J Pers Med. 2020 Nov 13;10(4):
pubmed: 33203021
Cancer Treat Rev. 2017 Sep;59:79-92
pubmed: 28759822
Metabolomics. 2019 Aug 16;15(8):110
pubmed: 31420744
Mol Aspects Med. 1993;14(4):287-371
pubmed: 8277832
Can J Hosp Pharm. 2017 Mar-Apr;70(2):99-106
pubmed: 28487576
Br J Cancer. 2014 Jul 15;111(2):395-406
pubmed: 24918814
Metabolites. 2020 Feb 07;10(2):
pubmed: 32046123
J Lipid Res. 1994 Dec;35(12):2292-304
pubmed: 7897326
Science. 2016 Sep 9;353(6304):1161-5
pubmed: 27609895
Radiother Oncol. 2020 Jun;147:15-21
pubmed: 32224314
Cell Mol Life Sci. 2016 Jun;73(11-12):2285-308
pubmed: 27066896
J Proteome Res. 2017 Apr 7;16(4):1753-1762
pubmed: 28271897
J Transl Med. 2013 Dec 05;11:299
pubmed: 24304975
Clin Chim Acta. 1999 Jan;279(1-2):77-96
pubmed: 10064120
Front Immunol. 2016 Dec 14;7:591
pubmed: 28018357
Lancet. 2000 Mar 18;355(9208):949-55
pubmed: 10768432